COMMUNIQUÉS West-GlobeNewswire

Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
24/07/2026
Company highlights the important role omega-3s play in children's brain development and cognitive function as they head back to the classroom Watsonville, CA, July 24, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals, the #1 [...]
HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA
24/07/2026
HorseFil is a men's dietary supplement formulated with a blend of carefully selected botanical extracts, amino acids, vitamins, and minerals designed to support men's overall wellness. According to the manufacturer, the [...]
Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare
24/07/2026
LONDRES, 24 juill. 2026 (GLOBE NEWSWIRE) -- Affidea, prestataire paneuropéen de cliniques de proximité, de diagnostics de pointe et de services de santé privés spécialisés, annonce aujourd’hui la signature d’un [...]
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
24/07/2026
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory [...]
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
24/07/2026
HUNTSVILLE, Ala., July 24, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug [...]
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
24/07/2026
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye injections for nAMD Positive recommendation is based on data from the LADDER, Archway and Portal studies [...]
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
24/07/2026
Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use outside the hospital setting Delivers IV-equivalent diuretic effect through [...]
MannKind Announces $50 Million Private Placement
24/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
24/07/2026
PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August [...]
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
24/07/2026
Asimov will help build out protein production and characterization capabilities at Boston University's AI-programmable cloud laboratory, one of 20 nodes in the new NSF national network. Asimov will use these [...]
Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference
24/07/2026
Poster presentation builds on Phase 1b PP353 data published in The Lancet's eClinicalMedicine, reinforcing the rationale for a targeted, non-opioid approach to chronic Low Back Pain with Modic changes London, UK, 24 [...]
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
24/07/2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
24/07/2026
NEW YORK and SYDNEY, July 24, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative [...]
Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
24/07/2026
Company plans to request re-examination following negative CHMP opinion for arimoclomol MAA Zevra continues to support access to arimoclomol for eligible patients through its global Expanded Access Program BOSTON, July [...]
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
24/07/2026
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protection NETANYA, Israel, July 24, 2026 (GLOBE [...]
Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
24/07/2026
Patients are told to verify their provider before starting GLP-1 treatment. The Los Angeles-based platform publishes its five licensed compounding pharmacies, the prescribing medical group, and full pricing so that [...]
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24/07/2026
SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]
Amwell® to report second quarter 2026 operating results
24/07/2026
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results [...]

Pages